Loading...

¿Qué puedo hacer para evitar ser estafado?

By |2025-06-23T12:52:20-04:00February 20th, 2024|Información en Español|

El SEC, el regulador federal de valores e inversiones, da los siguientes consejos:Haga preguntas y compruebe las respuestas. Los estafadores confían en la triste verdad de que muchas personas simplemente no se molestan en investigar antes de invertir. No es suficiente pedirle a un promotor más información o referencias: los estafadores no tienen ningún incentivo [...]

¿Puedo Demandar a mi Asesor Financiero?

By |2025-06-23T12:49:16-04:00February 14th, 2024|Información en Español|

Los asesores financieros están obligados a actuar con diligencia y cuidado en sus recomendaciones. Hay ciertas circunstancias en las que un cliente puede tener motivos para emprender acciones legales contra su asesor financiero: Negligencia o mala conducta: Si un asesor financiero no cumple con su deber de cuidado y actúa de manera negligente o fraudulenta [...]

Regulatory Settlement: LPL Penalized for Securities Violations

By |2024-02-08T18:34:24-05:00February 8th, 2024|Broker / Advisor Investigations|

In a recent development, LPL Financial has found itself in the spotlight, facing significant penalties totaling more than $6 million for various securities violations. The Financial Industry Regulatory Authority (Finra) disclosed that LPL Financial has agreed to pay a fine of $5.5 million alongside restitution of $651,375, with the additional imposition of a censure. Supervision [...]

Hoisting Expertise: Edward Jones Invests in Advisor Credentials

By |2024-02-08T18:29:19-05:00February 8th, 2024|Broker / Advisor Investigations|

In the dynamic world of financial investment, Edward Jones stands out for its unwavering commitment to excellence. Recent developments from the firm highlight a strategic focus on enhancing advisor credentials, promising significant benefits for investors and the industry as a whole. A Strategic Investment: Subsidizing Credentials Edward Jones's latest initiative involves subsidizing the costs associated [...]

An All-Inclusive Approval of Tax Legislation with Bonus Depreciation

By |2024-02-08T18:24:39-05:00February 8th, 2024|Broker / Advisor Investigations|

The full House of Representatives, in a late Wednesday session, passed H.R. 7024, titled the Tax Relief for American Families and Workers Act of 2024, with an overwhelming vote of 357 to 70. This landmark bill incorporates the much-anticipated tax bill with bonus depreciation feature at a full 100%, alongside significant measures such as research [...]

The Enforcement Actions Reference: SEC Charges Citigroup Subsidiaries for Regulatory Violations

By |2024-02-08T18:21:20-05:00February 8th, 2024|Broker / Advisor Investigations|

The Securities and Exchange Commission (SEC) has taken action against Citigroup Global Markets, Inc. (CGMI) and Citi International Financial Services, LLC (CIFS) for their failure to adhere to the disclosure requirements under Regulation Best Interest (Reg. BI) and the delivery mandate of Form Client Relationship Summary (Form CRS) during specific periods in 2020 and 2021. [...]

SEC vs. Coinbase: The SEC’s Allegations Against Coinbase

By |2024-02-08T18:13:13-05:00February 8th, 2024|Broker / Advisor Investigations|

The U.S. Securities and Exchange Commission (SEC) has lodged formal complaints against Coinbase, asserting that the company has breached securities legislation by not registering as a trading platform, as well as failing to register specific tokens and its cryptocurrency staking offerings. Cryptocurrency staking, a mechanism enabling the validation of transactions and the acquisition of rewards, [...]

SEC Charges Former CEO of Medical Device Startup Stimwave with $41 Million Fraud

By |2024-01-17T05:55:32-05:00January 16th, 2024|Broker / Advisor Investigations|

Miami, FL – In a significant development, the Securities and Exchange Commission (SEC) has charged Laura Tyler Perryman, the former CEO and co-founder of Florida-based medical device startup Stimwave Technologies Inc., with defrauding investors of approximately $41 million. This alarming case involves the creation and sale of a purportedly innovative medical device, part of which [...]

Go to Top